希氏-浦肯野系统起搏用于治疗起搏诱导性心肌病的临床研究进展  

Clinical Research Progress of His-Purkinje System Pacing in Treatment of Pacing-Induced Cardiomyopathy

作　　者：喻瑜 华伟[1] YU Yu;HUA Wei(Center of Arrhythmia,Fuwai Hospital,State Key Laboratory of Cardiovascular Disease,National Center for Cardiovascular Diseases,Chinese Academy of Medical Sciences,Peking Union Medical College,Beijing 100037,China)

机构地区：[1]中国医学科学院北京协和医学院,国家心血管病中心,心血管疾病国家重点实验室,阜外医院心律失常中心,北京100037

出　　处：《心血管病学进展》2022年第6期481-484,共4页Advances in Cardiovascular Diseases

摘　　要：起搏诱导性心肌病(PICM)是一种长期高比例心室起搏而引起的严重并发症。PICM患者通常需要调整起搏治疗方式。希氏-浦肯野系统起搏作为生理性起搏,包括希氏束起搏(HBP)和左束支起搏(LBBP),其电与机械同步性优于传统右心室起搏。现对HBP/LBBP改善PICM患者心功能的机制进行探讨,并根据现有临床研究证据归纳总结PICM患者实施HBP/LBBP后心功能改善情况。Pacing-induced cardiomyopathy(PICM)is a serious complication of prolonged ventricular pacing at a high rate.Patients with PICM often require adjustment of pacing therapy.The His-Purkinje system pacing is physiological,including His bundle pacing(HBP)and left bundle branch pacing(LBBP).Its electrical and mechanical synchronization is better than traditional right ventricular pacing.This paper discusses the mechanism of HBP/LBBP improving cardiac function in PICM patients.It summarizes the improvement of cardiac function in PICM patients after HBP/LBBP implementation based on the existing clinical research evidence.

关 键 词：起搏诱导性心肌病 希氏-浦肯野系统起搏 生理性起搏 

分 类 号：R54[医药卫生—心血管疾病]